Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 7 studies | 19% ± 4% | |
plasmacytoid dendritic cell | 7 studies | 24% ± 10% | |
endothelial cell | 6 studies | 24% ± 5% | |
epithelial cell | 6 studies | 31% ± 12% | |
adipocyte | 6 studies | 24% ± 4% | |
ciliated cell | 6 studies | 27% ± 9% | |
macrophage | 4 studies | 18% ± 1% | |
fibroblast | 4 studies | 20% ± 4% | |
astrocyte | 4 studies | 27% ± 8% | |
glutamatergic neuron | 4 studies | 43% ± 15% | |
classical monocyte | 3 studies | 17% ± 2% | |
GABAergic neuron | 3 studies | 43% ± 2% | |
dendritic cell | 3 studies | 31% ± 5% | |
basal cell | 3 studies | 32% ± 3% | |
neuron | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1742.02 | 1445 / 1445 | 100% | 39.53 | 183 / 183 |
intestine | 100% | 1533.50 | 966 / 966 | 100% | 44.41 | 527 / 527 |
ovary | 100% | 2316.90 | 180 / 180 | 100% | 28.29 | 430 / 430 |
pancreas | 100% | 1954.90 | 328 / 328 | 100% | 41.90 | 178 / 178 |
stomach | 100% | 1535.19 | 359 / 359 | 100% | 40.43 | 286 / 286 |
uterus | 100% | 1683.18 | 170 / 170 | 100% | 51.37 | 459 / 459 |
thymus | 100% | 1551.51 | 653 / 653 | 100% | 45.63 | 604 / 605 |
lung | 100% | 1473.65 | 577 / 578 | 100% | 44.95 | 1155 / 1155 |
prostate | 100% | 1624.19 | 245 / 245 | 100% | 30.29 | 501 / 502 |
breast | 100% | 1662.00 | 459 / 459 | 100% | 39.70 | 1114 / 1118 |
kidney | 100% | 1497.83 | 89 / 89 | 100% | 26.62 | 897 / 901 |
bladder | 100% | 1654.33 | 21 / 21 | 99% | 46.11 | 501 / 504 |
adrenal gland | 100% | 2202.34 | 258 / 258 | 99% | 36.86 | 228 / 230 |
skin | 100% | 1919.06 | 1808 / 1809 | 99% | 34.76 | 468 / 472 |
brain | 99% | 893.61 | 2612 / 2642 | 100% | 22.23 | 705 / 705 |
liver | 100% | 1219.15 | 226 / 226 | 96% | 21.63 | 391 / 406 |
adipose | 100% | 1959.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 65.99 | 29 / 29 |
spleen | 100% | 1649.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 53.56 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.25 | 1 / 1 |
blood vessel | 100% | 1308.22 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 842.65 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 1355.85 | 870 / 929 | 0% | 0 | 0 / 0 |
muscle | 93% | 631.87 | 746 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 17.48 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_0005673 | Cellular component | transcription factor TFIIE complex |
GO_0005669 | Cellular component | transcription factor TFIID complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0001097 | Molecular function | TFIIH-class transcription factor complex binding |
GO_0003677 | Molecular function | DNA binding |
GO_0016251 | Molecular function | RNA polymerase II general transcription initiation factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | GTF2E2 |
Protein name | General transcription factor IIE subunit 2 Transcription initiation factor IIE subunit beta (TFIIE-beta) (General transcription factor IIE subunit 2) |
Synonyms | TF2E2 |
Description | FUNCTION: Recruits TFIIH to the initiation complex and stimulates the RNA polymerase II C-terminal domain kinase and DNA-dependent ATPase activities of TFIIH. Both TFIIH and TFIIE are required for promoter clearance by RNA polymerase. . FUNCTION: Recruits TFIIH to the initiation complex and stimulates the RNA polymerase II C-terminal domain kinase and DNA-dependent ATPase activities of TFIIH. Both TFIIH and TFIIE are required for promoter clearance by RNA polymerase. . |
Accessions | P29084 ENST00000518599.5 ENST00000518445.1 E5RIW4 ENST00000355904.9 E5RH41 E5RK24 ENST00000523499.5 |